Clinicopathologic characteristics of neuroendocrine tumors with assessment by digital image analysis for Ki-67 index with a focus on the gastroenteropancreatic tract: a single-center study

被引:0
作者
Park, Ji Hyun [1 ]
Shin, Su-Jin [1 ]
Jeon, Nara [1 ]
Lim, Beom Jin [1 ]
机构
[1] Yonsei Univ, Coll Med, Dept Pathol, 50-1 Yonsei Rd, Seoul 03722, South Korea
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 2023年 / 16卷 / 09期
关键词
Neuroendocrine tumor; eyeball estimation; digital image analysis; Ki-67 labeling index; CLASSIFICATION; DIAGNOSIS; KI67; SYSTEM; GRADE; KOREA; NETS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Neuroendocrine tumors (NETs) are a heterogeneous group of tumors that arise at various sites throughout the body. The gastroenteropancreatic (GEP) tract is the most common site of NETs. We investigated the clinicopathologic features of patients with GEP-NETs and the utility of digital image analysis, which was compared to eyeball estimation, a conventional method used to determine the Ki-67 labeling index. Methods: The clinicopathologic data of GEP-NET patients at Gangnam Severance Hospital from January 2008 to October 2019 were retrospectively analyzed. Each case was reclassified according to the 2019 World Health Organization classification system, to which the classification of grade 3 was added. Comparisons between eyeball estimation and the digital image analysis method for Ki-67 index assessment were performed by calculating Cohen's kappa (k) coefficient. Results: In total, 345 patients with GEP-NETs were enrolled. The mean age was 49.3 (range 13-79) years, with more male (61.1%) than female patients. The primary tumor sites were the rectum (70.1%), pancreas (12.5%), stomach (6.7%), and duodenum (5.8%). Overall, 298 (86.4%), 35 (10.1%), 2 (0.6%), and 10 (2.9%) patients exhibited grade 1, 2, and 3 and neuroendocrine carcinoma, respectively. Statistical analysis revealed that age > 50 years, tumor size > 2 cm, and presence of lymphovascular invasion, nodal metastasis, and distant metastasis were significantly associated with short overall survival. Additionally, 283 patients underwent digital image analysis of the Ki-67 index, and substantial agreement was found between the two methods (kappa value: 0.765). Conclusions: Eyeball estimation revealed non-inferior results compared with digital image analysis. Further research is needed to evaluate the possibility of using digital image analysis as an alternative analysis method.
引用
收藏
页码:225 / 234
页数:10
相关论文
共 35 条
[1]   Ki67 Labeling Index in Neuroendocrine Tumors of the Gastrointestinal and Pancreatobiliary Tract To Count or Not to Count Is Not the Question, But Rather How to Count [J].
Adsay, Volkan .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (12) :1743-1746
[2]   The NANETS Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Neuroendocrine Tumors (NETs) Well-Differentiated NETs of the Distal Colon and Rectum [J].
Anthony, Lowell B. ;
Strosberg, Jonathan R. ;
Klimstra, David S. ;
Maples, William J. ;
O'Dorisio, Thomas M. ;
Warner, Richard R. P. ;
Wiseman, Gregory A. ;
Benson, Al B., III ;
Pommier, Rodney F. .
PANCREAS, 2010, 39 (06) :767-774
[3]   The High-grade (WHO G3) Pancreatic Neuroendocrine Tumor Category Is Morphologically and Biologically Heterogenous and Includes Both Well Differentiated and Poorly Differentiated Neoplasms [J].
Basturk, Olca ;
Yang, Zhaohai ;
Tang, Laura H. ;
Hruban, Ralph H. ;
Adsay, Volkan ;
McCall, Chad M. ;
Krasinskas, Alyssa M. ;
Jang, Kee-Taek ;
Frankel, Wendy L. ;
Balci, Serdar ;
Sigel, Carlie ;
Klimstra, David S. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (05) :683-690
[4]   Pathologic Considerations in Gastroenteropancreatic Neuroendocrine Tumors [J].
Bellizzi, Andrew M. .
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2020, 29 (02) :185-+
[5]  
Bosman F. T., 2010, WHO classification of tumours of the digestive system
[6]   Ki-67 Proliferation Index Assessment in Gastroenteropancreatic Neuroendocrine Tumors by Digital Image Analysis With Stringent Case and Hotspot Level Concordance Requirements [J].
Boukhar, Sarag A. ;
Gosse, Matthew D. ;
Bellizzi, Andrew M. ;
Rajan, Anand .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2021, 156 (04) :607-619
[7]  
Chi Yi-he-ba-li, 2013, Zhonghua Zhong Liu Za Zhi, V35, P67, DOI 10.3760/cma.j.issn.0253-3766.2013.01.015
[8]   Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study [J].
Cho, Mee-Yon ;
Kim, Joon Mee ;
Sohn, Jin Hee ;
Kim, Mi-Jung ;
Kim, Kyoung-Mee ;
Kim, Woo Ho ;
Kim, Hyunki ;
Kook, Myeong-Cherl ;
Park, Do Youn ;
Lee, Jae Hyuk ;
Chang, HeeKyung ;
Jung, Eun Sun ;
Kim, Hee Kyung ;
Jin, So-Young ;
Choi, Joon Hyuk ;
Gu, Mi Jin ;
Kim, Sujin ;
Kang, Mi Seon ;
Cho, Chang Ho ;
Park, Moon-Il ;
Kang, Yun Kyung ;
Kim, Youn Wha ;
Yoon, Sun Och ;
Bae, Han Ik ;
Joo, Mee ;
Moon, Woo Sung ;
Kang, Dae Young ;
Chang, Sei Jin .
CANCER RESEARCH AND TREATMENT, 2012, 44 (03) :157-165
[9]   Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement [J].
Coriat, Romain ;
Walter, Thomas ;
Terris, Benoit ;
Couvelard, Anne ;
Ruszniewski, Philippe .
ONCOLOGIST, 2016, 21 (10) :1191-1199
[10]   Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States [J].
Dasari, Arvind ;
Shen, Chan ;
Halperin, Daniel ;
Zhao, Bo ;
Zhou, Shouhao ;
Xu, Ying ;
Shih, Tina ;
Yao, James C. .
JAMA ONCOLOGY, 2017, 3 (10) :1335-1342